Trexquant Investment LP
Position in TNXP — Tonix Pharmaceuticals Holding Corp.
CIK 1633445
STAMFORD, CT
Position in TNXP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$811,982
New position
Shares Held
63,635
first reported quarter
Ownership
0.371%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 103 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 91%
Shared 0%
None 9%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. TNXP ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | TWST |
Twist Bioscience Corp
|
255,271 | $26,262,280 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 7 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 |
All Filings in TNXP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $811,982 | 63,635 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||